• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus.

作者信息

Janda Z, Adam E, Vonka V

出版信息

Arch Gesamte Virusforsch. 1967;20(1):87-98.

PMID:4299774
Abstract
摘要

相似文献

1
Properties of a new type 3 attenuated poliovirus. VI. Alimentary tract resistance in children fed previously with type 3 Sabin vaccine to reinfection with homologous and heterologous type 3 attenuated poliovirus.一种新型3型减毒脊髓灰质炎病毒的特性。VI. 先前接种过3型萨宾疫苗的儿童对同源和异源3型减毒脊髓灰质炎病毒再感染的消化道抵抗力。
Arch Gesamte Virusforsch. 1967;20(1):87-98.
2
Immunization with inactivated poliovirus vaccine and attenuated type 3 poliovirus. II. Parallel vaccinations and cross-wise revaccination in school children with the Sabin and WM3 attenuated strains.用灭活脊髓灰质炎病毒疫苗和3型减毒脊髓灰质炎病毒进行免疫接种。II. 用萨宾株和WM3减毒株对学童进行平行接种和交叉再接种。
J Pediatr. 1969 Aug;75(2):273-80. doi: 10.1016/s0022-3476(69)80398-7.
3
Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.使用用萨宾疫苗病毒制备的单克隆抗体对在加拿大分离出的脊髓灰质炎病毒株进行特性鉴定。
Dev Biol Stand. 1984;57:141-9.
4
[Seroconversion with trivalent Sabin vaccine in children less than four years of age].[4岁以下儿童三价萨宾疫苗的血清转化情况]
Bol Med Hosp Infant Mex. 1989 Aug;46(8):517-25.
5
Evaluation of Sabin live poliovirus vaccine in Japan. II. Clinical, virologic and immunologic effects of vaccine in children.日本脊髓灰质炎减毒活疫苗评估。II. 疫苗对儿童的临床、病毒学及免疫学效应
Jpn J Med Sci Biol. 1966 Dec;19(6):277-91. doi: 10.7883/yoken1952.19.277.
6
[Virologic and serologic study on subjects vaccinated with Sabin vaccine, living in a community].[对居住在某社区、接种了萨宾疫苗的人群进行的病毒学和血清学研究]
Boll Ist Sieroter Milan. 1966 May-Jun;45(5-6):236-49.
7
Antigenic modification of attenuated Sabin type 1 poliovirus by in vitro passages at supraoptimal temperatures.通过在超最佳温度下进行体外传代对减毒的萨宾1型脊髓灰质炎病毒进行抗原修饰。
Dev Biol Stand. 1985;60:343-7.
8
[Excretion rates after Sabin oral vaccination against poliomyelitis in Tyrol].[蒂罗尔地区口服萨宾脊髓灰质炎疫苗后的排泄率]
Arch Hyg Bakteriol. 1968 Dec;152(5):410-4.
9
[Poliovirus circulation and the immunological status of school children in Alessandria after the introduction of Sabin vaccination].[萨宾疫苗接种后亚历山德里亚地区脊髓灰质炎病毒传播情况及学童免疫状况]
G Ig Med Prev. 1971 Jan-Mar;12(1):69-76.
10
Properties of a new type 3 attenuated poliovirus. V. Neurovirulence tests in monkeys after a passage through the human alimentary tract.一种新型3型减毒脊髓灰质炎病毒的特性。V. 经人体消化道传代后在猴子身上进行的神经毒力试验。
Arch Gesamte Virusforsch. 1965;15(5):681-9.

引用本文的文献

1
USOL-D bac (type 3 poliovirus) vaccine studies.USOL-D杆菌（3型脊髓灰质炎病毒）疫苗研究。
Bull World Health Organ. 1969;40(2):295-300.
2
Evidence on the safety and efficacy of live poliomyelitis vaccines currently in use, with special reference to type 3 poliovirus.关于目前使用的脊髓灰质炎活疫苗安全性和有效性的证据，特别提及3型脊髓灰质炎病毒。
Bull World Health Organ. 1969;40(6):925-45.

本文引用的文献

1
PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. 3. A SMALL SCALE TRIAL WITH USOL-D BAC VIRUS IN A CLOSED CHILD COMMUNITY.一种新型3型减毒脊髓灰质炎病毒的特性。3. 在封闭儿童社区中使用USOL-D杆菌病毒进行的小规模试验。
Arch Gesamte Virusforsch. 1965;15:234-43.
2
PROPERTIES OF A NEW ATTENUATED TYPE 3 POLIOVIRUS. II. NEUROVIRULENCE TESTS ON MONKEYS.一种新型减毒3型脊髓灰质炎病毒的特性。II. 对猴子的神经毒力试验。
Arch Gesamte Virusforsch. 1965;15:220-33.
3
THE PROPERTIES OF A NEW TYPE 3 ATTENUATED POLIOVIRUS. I. DERIVATION OF NEW TYPE 3 ATTENUATED POLIOVIRUSES AND THEIR LABORATORY CHARACTERISTICS.
Arch Gesamte Virusforsch. 1964 Jun 17;14:599-610. doi: 10.1007/BF01555117.
4
THE USE OF THE COMPLEMENT FIXATION TEST FOR TYPING OF POLIOMYELITIC VIRUSES.补体结合试验在脊髓灰质炎病毒分型中的应用。
J Hyg Epidemiol Microbiol Immunol. 1964;8:264-8.
5
STRAIN SPECIFICITY OF TYPE 1 NEUTRALIZING ANTIBODIES DEVELOPING IN CHILDREN FED WITH TYPE 1 SABIN'S ATTENUATED VIRUS (LSC 2AB).接种1型萨宾减毒活疫苗（LSC 2AB）的儿童体内产生的1型中和抗体的毒株特异性
Arch Gesamte Virusforsch. 1964;14:169-76. doi: 10.1007/BF01555089.
6
Infection induced by oral administration of attenuated poliovirus to persons possessing homotypic antibody.向具有同型抗体的人口服减毒脊髓灰质炎病毒引起的感染。
J Exp Med. 1957 Jul 1;106(1):159-77. doi: 10.1084/jem.106.1.159.
7
Properties and behavior of orally administered attenuated poliovirus vaccine.口服减毒脊髓灰质炎疫苗的特性与行为
J Am Med Assoc. 1957 Jul 13;164(11):1216-23. doi: 10.1001/jama.1957.62980110008008.
8
Present status of attenuated live-virus poliomyelitis vaccine.减毒活疫苗脊髓灰质炎疫苗的现状。
J Am Med Assoc. 1956 Dec 29;162(18):1589-96. doi: 10.1001/jama.1956.02970350005002.
9
Immunization of infants with living attenuated poliomyelitis virus; laboratory investigations of alimentary infection and antibody response in infants under six months of age with congenitally acquired antibodies.用减毒活脊髓灰质炎病毒对婴儿进行免疫；对6个月以下具有先天性获得性抗体的婴儿进行消化道感染及抗体反应的实验室研究。
J Am Med Assoc. 1956 Dec 1;162(14):1281-8.
10
Administration of an attenuated type I poliomyelitis virus to human subjects.向人类受试者施用减毒I型脊髓灰质炎病毒。
Proc Soc Exp Biol Med. 1954 Jun;86(2):244-7. doi: 10.3181/00379727-86-21062.